Amarin Corp Plcuk (AMRN) Total Current Liabilities (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Total Current Liabilities of $179.6 million for Q1 2026, up 10.61% YoY from $162.4 million in Q1 2025, and down 7.62% sequentially from $194.5 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Total Current Liabilities (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Total Current Liabilities across 17 years of filings, most recently posting $179.6 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities rose 10.61% year-over-year to $179.6 million; the TTM figure through Mar 2026 stood at $179.6 million (up 10.61% YoY), while the FY2025 annual figure was $194.5 million, up 8.06% from the prior year.
  • Total Current Liabilities fell to $179.6 million in Q1 2026, from $194.5 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for AMRN reached as high as $361.6 million in Q2 2022 and fell as low as $162.4 million in Q1 2025.
  • The 5-year median for Total Current Liabilities is $230.5 million (2024), against an average of $234.8 million.
  • Annual changes were most pronounced in 2024 — Total Current Liabilities tumbled 30.6% — and 2026, when it gained 10.61%.
  • A 5-year view of Total Current Liabilities shows it stood at $259.5 million in 2022, then slipped by 0.08% to $259.3 million in 2023, then plunged by 30.6% to $179.9 million in 2024, then increased by 8.06% to $194.5 million in 2025, then decreased by 7.62% to $179.6 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $179.6 million, $194.5 million, and $182.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn 36.63 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 57.72 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn 42.10 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -32.57 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn 26.95 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn 24.96 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn 9.48 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn 34.35 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn 179.64 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 179.64 Mn
Dec 31, 2025 194.46 Mn
Sep 30, 2025 182.23 Mn
Jun 30, 2025 185.95 Mn
Mar 31, 2025 162.41 Mn
Dec 31, 2024 179.95 Mn
Sep 30, 2024 201.55 Mn
Jun 30, 2024 230.54 Mn
Mar 31, 2024 224.38 Mn
Dec 31, 2023 259.28 Mn
Sep 30, 2023 266.69 Mn
Jun 30, 2023 270.93 Mn
Mar 31, 2023 244.24 Mn
Dec 31, 2022 259.48 Mn
Sep 30, 2022 287.36 Mn
Jun 30, 2022 361.57 Mn
Mar 31, 2022 300.57 Mn
Dec 31, 2021 370.68 Mn
Sep 30, 2021 364.75 Mn
Jun 30, 2021 370.44 Mn